Es gab 50 kürzliche Insider-Transaktionen für Anavex Life Sciences Corp. (AVXL), darunter 43 Käufe und 7 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $24.96M und die gesamten Insider-Verkäufe auf $3.65M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Missling Christopher U, Boenisch Sandra, Thomas Steffen. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — AVXL
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-06 |
Missling Christopher U |
President and CEO |
RSU-Zuteilung |
125,000 |
$8.58 |
$1.07M |
125,000 |
| 2026-01-06 |
Boenisch Sandra |
Pfo & Treasurer |
RSU-Zuteilung |
12,500 |
$8.58 |
$107.25K |
12,500 |
| 2025-10-02 |
Missling Christopher U |
President and CEO |
RSU-Zuteilung |
125,000 |
$5.36 |
$670K |
250,000 |
| 2025-10-02 |
Boenisch Sandra |
Pfo & Treasurer |
RSU-Zuteilung |
12,500 |
$5.36 |
$67K |
25,000 |
| 2025-09-11 |
Missling Christopher U |
President and CEO |
Optionsausübung (Verkauf) |
187,500 |
$5.04 |
$945K |
- |
| 2025-08-20 |
Missling Christopher U |
President and CEO |
RSU-Zuteilung |
125,000 |
$8.58 |
$1.07M |
125,000 |
| 2025-08-20 |
Boenisch Sandra |
Pfo & Treasurer |
RSU-Zuteilung |
12,500 |
$8.58 |
$107.25K |
12,500 |
| 2025-06-05 |
Thomas Steffen |
Director |
Optionsausübung (Verkauf) |
50,000 |
$1.76 |
$88K |
- |
| 2025-04-28 |
Missling Christopher U |
President and CEO |
RSU-Zuteilung |
125,000 |
$8.57 |
$1.07M |
125,000 |
| 2025-04-28 |
Boenisch Sandra |
Pfo & Treasurer |
RSU-Zuteilung |
12,500 |
$8.57 |
$107.13K |
12,500 |
| 2025-03-31 |
Skarpelos Athanasios |
Director |
RSU-Zuteilung |
50,000 |
$8.58 |
$429K |
50,000 |
| 2025-03-31 |
Thomas Steffen |
Director |
RSU-Zuteilung |
50,000 |
$8.58 |
$429K |
50,000 |
| 2025-03-31 |
Donhauser Peter D.o. |
Director |
RSU-Zuteilung |
50,000 |
$8.58 |
$429K |
50,000 |
| 2025-03-31 |
Velden Claus Vander |
Director |
RSU-Zuteilung |
50,000 |
$8.58 |
$429K |
50,000 |
| 2025-03-31 |
Ma Jiong |
Director |
RSU-Zuteilung |
50,000 |
$8.58 |
$429K |
50,000 |
| 2025-03-24 |
Missling Christopher U |
President and CEO |
Optionsausübung (Verkauf) |
500,000 |
$0.92 |
$460K |
- |
| 2025-01-15 |
Missling Christopher U |
President and CEO |
RSU-Zuteilung |
125,000 |
$8.57 |
$1.07M |
125,000 |
| 2025-01-15 |
Boenisch Sandra |
Pfo & Treasurer |
RSU-Zuteilung |
12,500 |
$8.57 |
$107.13K |
12,500 |
| 2024-12-19 |
Missling Christopher U |
President and CEO |
RSU-Zuteilung |
125,000 |
$5.36 |
$670K |
125,000 |
| 2024-12-19 |
Boenisch Sandra |
Pfo & Treasurer |
RSU-Zuteilung |
12,500 |
$5.36 |
$67K |
12,500 |
| 2024-11-19 |
Missling Christopher U |
President and CEO |
RSU-Zuteilung |
125,000 |
$10.09 |
$1.26M |
250,000 |
| 2024-11-19 |
Boenisch Sandra |
Pfo & Treasurer |
RSU-Zuteilung |
10,000 |
$10.09 |
$100.9K |
20,000 |
| 2024-06-14 |
Donhauser Peter D.o. |
Director |
Informierter Kauf |
2,835 |
$3.64 |
$10.32K |
5,000 |
| 2024-05-15 |
Thomas Steffen |
Director |
Informierter Kauf |
5,000 |
$4.52 |
$22.6K |
5,000 |
| 2024-03-28 |
Missling Christopher U |
President and CEO |
Optionsausübung (Verkauf) |
73,380 |
$1.32 |
$96.86K |
- |
| 2024-02-20 |
Skarpelos Athanasios |
Director |
RSU-Zuteilung |
50,000 |
$5.36 |
$268K |
50,000 |
| 2024-02-20 |
Thomas Steffen |
Director |
RSU-Zuteilung |
50,000 |
$5.36 |
$268K |
50,000 |
| 2024-02-20 |
Donhauser Peter D.o. |
Director |
RSU-Zuteilung |
50,000 |
$5.36 |
$268K |
50,000 |
| 2024-02-20 |
Velden Claus Vander |
Director |
RSU-Zuteilung |
50,000 |
$5.36 |
$268K |
50,000 |
| 2024-02-20 |
Ma Jiong |
Director |
RSU-Zuteilung |
50,000 |
$5.36 |
$268K |
50,000 |
| 2024-01-02 |
Missling Christopher U |
President and CEO |
RSU-Rückgabe |
125,000 |
$10.09 |
$1.26M |
125,000 |
| 2024-01-02 |
Boenisch Sandra |
Pfo & Treasurer |
RSU-Zuteilung |
10,000 |
$10.09 |
$100.9K |
10,000 |
| 2023-06-29 |
Missling Christopher U |
President and CEO |
Optionsausübung (Verkauf) |
232,000 |
$1.60 |
$371.2K |
- |
| 2023-06-28 |
Missling Christopher U |
President and CEO |
Optionsausübung (Verkauf) |
268,000 |
$1.60 |
$428.8K |
232,000 |
| 2023-03-31 |
Skarpelos Athanasios |
Director |
RSU-Zuteilung |
50,000 |
$8.57 |
$428.5K |
50,000 |
| 2023-03-31 |
Thomas Steffen |
Director |
RSU-Zuteilung |
50,000 |
$8.57 |
$428.5K |
50,000 |
| 2023-03-31 |
Donhauser Peter D.o. |
Director |
RSU-Zuteilung |
50,000 |
$8.57 |
$428.5K |
50,000 |
| 2023-03-31 |
Velden Claus Vander |
Director |
RSU-Zuteilung |
50,000 |
$8.57 |
$428.5K |
50,000 |
| 2023-03-31 |
Ma Jiong |
Director |
RSU-Zuteilung |
50,000 |
$8.57 |
$428.5K |
50,000 |
| 2022-06-27 |
Skarpelos Athanasios |
Director |
RSU-Zuteilung |
50,000 |
- |
- |
50,000 |
| 2022-06-27 |
Thomas Steffen |
Director |
RSU-Zuteilung |
50,000 |
- |
- |
50,000 |
| 2022-06-27 |
Donhauser Peter D.o. |
Director |
RSU-Zuteilung |
50,000 |
$10.09 |
$504.5K |
50,000 |
| 2022-06-27 |
Velden Claus Vander |
Director |
RSU-Zuteilung |
50,000 |
- |
- |
50,000 |
| 2022-06-27 |
Ma Jiong |
Director |
RSU-Zuteilung |
50,000 |
- |
- |
50,000 |
| 2022-05-25 |
Skarpelos Athanasios |
Director |
Optionsausübung |
50,000 |
- |
- |
- |
| 2021-08-02 |
Missling Christopher U |
Chief Executive Officer |
RSU-Zuteilung |
500,000 |
$18.11 |
$9.06M |
500,000 |
| 2021-08-02 |
Skarpelos Athanasios |
Director |
RSU-Zuteilung |
25,000 |
$18.11 |
$452.75K |
25,000 |
| 2021-08-02 |
Thomas Steffen |
Director |
RSU-Zuteilung |
25,000 |
$18.11 |
$452.75K |
25,000 |
| 2021-08-02 |
Boenisch Sandra |
Pfo and Treasurer |
RSU-Zuteilung |
40,000 |
$18.11 |
$724.4K |
40,000 |
| 2021-08-02 |
Donhauser Peter D.o. |
Director |
RSU-Zuteilung |
25,000 |
$18.11 |
$452.75K |
25,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
